Advertisement

Topics

GSK sells eczema and psoriasis drug to Dermavant for £250m

05:54 EDT 13 Jul 2018 | PMLIVE

The British group is selling off assets outside core therapy areas to boost R&D

Original Article: GSK sells eczema and psoriasis drug to Dermavant for £250m

NEXT ARTICLE

More From BioPortfolio on "GSK sells eczema and psoriasis drug to Dermavant for £250m"

Advertisement
Quick Search
Advertisement
Advertisement